A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

NCT03465878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: LY900014
DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company